Medical Devices

Revance unites its top acne treatment, PanOxyl, and microneedling device, SkinPen, in a strategic play to capture the holistic skincare market.

With $12M in new funding, Veritas Aortic Solutions aims to replace high-risk open-heart surgery with a groundbreaking transcatheter device for the aorta.

A new study on runners reveals how vagus nerve stimulation improves recovery and sleep, pioneering a 'Stress Fitness' approach for athletes.

Facing delisting, biotech firm Cuprina Holdings executes a reverse split and appeals to Nasdaq. Will the high-stakes gamble pay off for the company?

SurGenTec's FDA clearance for its ION-C™ system, now compatible with Medtronic navigation, signals a new era of precision in cervical spine surgery.

As a Chinese firm brings its water-saving hydrogels to Australia, it reveals a deeper shift in agritech: from selling products to deploying integrated, climate-resilient solutions.

Gene Solutions' SPOT-MAS 10 test gains FDA Breakthrough Designation, accelerating its path to the U.S. market and heralding a new era in early cancer detection.

Sysmex America's new XR-Series hematology analyzer promises to transform clinical labs with faster results, deeper insights, and a seamless workflow upgrade.

Meet the Austin trio behind Alafair Biosciences, whose innovative hydrogel technology is transforming surgical recovery and earning them top entrepreneurial honors.

A new partnership aims to deploy AI-powered imaging and advanced training across Asia Pacific, tackling the region's leading cause of death head-on.

A new manufacturing deal positions ViCentra to serve thousands more diabetes patients in Europe and sets the stage for a future U.S. market challenge.

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

The cold storage giant's strategic acquisition of a pharma-certified specialist signals a major shift into the high-stakes world of medical logistics.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

Former Samsung smartphone chief Blake Gaiser joins Eyesafe, signaling a major push to embed vision wellness tech into every device you own.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

Following its X3D acquisition, Catalyst MedTech unveils an expanded portfolio and a new strategy to tackle aging equipment and modernize nuclear medicine.

A Chinese firm services ultrasound machines in 140+ countries, challenging OEM dominance and helping hospitals cut costs and extend equipment life.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.